Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Hellmann, Matthew D, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de la Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenegre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie R, O’Byrne, Kenneth J, Geese, William J, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar K, Kasinathan, Ravi S, Nathan, Faith E, Ramalingam, Suresh S
Published in The New England journal of medicine (21.11.2019)
Published in The New England journal of medicine (21.11.2019)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in The New England journal of medicine (31.05.2018)
Published in The New England journal of medicine (31.05.2018)
Get full text
Journal Article
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature
Barr, Martin P, Gray, Steven G, Hoffmann, Andreas C, Hilger, Ralf A, Thomale, Juergen, O'Flaherty, John D, Fennell, Dean A, Richard, Derek, O'Leary, John J, O'Byrne, Kenneth J
Published in PloS one (17.01.2013)
Published in PloS one (17.01.2013)
Get full text
Journal Article
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
Spigel, David R, Edelman, Martin J, O'Byrne, Kenneth, Paz-Ares, Luis, Mocci, Simonetta, Phan, See, Shames, David S, Smith, Dustin, Yu, Wei, Paton, Virginia E, Mok, Tony
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
The fructose-bisphosphate, Aldolase A (ALDOA), facilitates DNA-PKcs and ATM kinase activity to regulate DNA double-strand break repair
Sobanski, Thais, Suraweera, Amila, Burgess, Joshua T., Richard, Iain, Cheong, Chee Man, Dave, Keyur, Rose, Maddison, Adams, Mark N., O’Byrne, Kenneth J., Richard, Derek J., Bolderson, Emma
Published in Scientific reports (13.09.2023)
Published in Scientific reports (13.09.2023)
Get full text
Journal Article
The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer
O'Callaghan, Dermot S., O'Donnell, Dearbhaile, O'Connell, Finbarr, O'Byrne, Kenneth J.
Published in Journal of thoracic oncology (01.12.2010)
Published in Journal of thoracic oncology (01.12.2010)
Get full text
Journal Article
Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage
Bolderson, Emma, Burgess, Joshua T., Li, Jun, Gandhi, Neha S., Boucher, Didier, Croft, Laura V., Beard, Samuel, Plowman, Jennifer J., Suraweera, Amila, Adams, Mark N., Naqi, Ali, Zhang, Shu-Dong, Sinclair, David A., O’Byrne, Kenneth J., Richard, Derek J.
Published in Nature communications (03.12.2019)
Published in Nature communications (03.12.2019)
Get full text
Journal Article
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
Shah, Esha T., Molloy, Christopher, Gough, Madeline, Kryza, Thomas, Samuel, Selwin G., Tucker, Amos, Bhatia, Maneet, Ferguson, Genevieve, Heyman, Rebecca, Vora, Shivam, Monkman, James, Bolderson, Emma, Kulasinghe, Arutha, He, Yaowu, Gabrielli, Brian, Hooper, John D., Richard, Derek J., O’Byrne, Kenneth J., Adams, Mark N.
Published in British journal of cancer (20.04.2024)
Published in British journal of cancer (20.04.2024)
Get full text
Journal Article
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer
Govindan, Ramaswamy, Szczesna, Aleksandra, Ahn, Myung-Ju, Schneider, Claus-Peter, Gonzalez Mella, Pablo Fernando, Barlesi, Fabrice, Han, Baohui, Ganea, Doina Elena, Von Pawel, Joachim, Vladimirov, Vladimir, Fadeeva, Natalia, Lee, Ki Hyeong, Kurata, Takayasu, Zhang, Li, Tamura, Tomohide, Postmus, Pieter E, Jassem, Jacek, O'Byrne, Kenneth, Kopit, Justin, Li, Mingshun, Tschaika, Marina, Reck, Martin
Published in Journal of clinical oncology (20.10.2017)
Published in Journal of clinical oncology (20.10.2017)
Get full text
Journal Article
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227
Brahmer, Julie R, Lee, Jong-Seok, Ciuleanu, Tudor-Eliade, Bernabe Caro, Reyes, Nishio, Makoto, Urban, Laszlo, Audigier-Valette, Clarisse, Lupinacci, Lorena, Sangha, Randeep, Pluzanski, Adam, Burgers, Jacobus, Mahave, Mauricio, Ahmed, Samreen, Schoenfeld, Adam J, Paz-Ares, Luis G, Reck, Martin, Borghaei, Hossein, O'Byrne, Kenneth J, Gupta, Ravi G, Bushong, Judith, Li, Li, Blum, Steven I, Eccles, Laura J, Ramalingam, Suresh S
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
YANG, James Chih-Hsin, HIRSH, Vera, PALMER, Michael, SEQUIST, Lecia V, SCHULER, Martin, YAMAMOTO, Nobuyuki, O'BYRNE, Kenneth J, MOK, Tony S. K, ZAZULINA, Victoria, SHAHIDI, Mehdi, LUNGERSHAUSEN, Juliane, MASSEY, Dan
Published in Journal of clinical oncology (20.09.2013)
Published in Journal of clinical oncology (20.09.2013)
Get full text
Journal Article
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Pirker, Robert, Prof, Pereira, Jose R, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Park, Keunchil, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried EE, MD, Paz-Ares, Luis, MD, Störkel, Stephan, Prof, Schumacher, Karl-Maria, MD, von Heydebreck, Anja, PhD, Celik, Ilhan, Prof, O'Byrne, Kenneth J, Prof
Published in The lancet oncology (2012)
Published in The lancet oncology (2012)
Get full text
Journal Article
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
SEQUIST, Lecia V, YANG, James Chih-Hsin, SU, Wu-Chou, BENNOUNA, Jaafar, KATO, Terufumi, GORBUNOVA, Vera, KI HYEONG LEE, SHAH, Riyaz, MASSEY, Dan, ZAZULINA, Victoria, SHAHIDI, Mehdi, SCHULER, Martin, YAMAMOTO, Nobuyuki, O'BYRNE, Kenneth, HIRSH, Vera, MOK, Tony, GEATER, Sarayut Lucien, ORLOV, Sergey, TSAI, Chun-Ming, BOYER, Michael
Published in Journal of clinical oncology (20.09.2013)
Published in Journal of clinical oncology (20.09.2013)
Get full text
Journal Article
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
Collins, Denis M, Madden, Stephen F, Gaynor, Nicola, AlSultan, Dalal, Le Gal, Marion, Eustace, Alex J, Gately, Kathy A, Hughes, Clare, Davies, Anthony M, Mahgoub, Thamir, Ballot, Jo, Toomey, Sinead, O'Connor, Darran P, Gallagher, William M, Holmes, Frankie A, Espina, Virginia, Liotta, Lance, Hennessy, Bryan T, O'Byrne, Kenneth J, Hasmann, Max, Bossenmaier, Birgit, O'Donovan, Norma, Crown, John
Published in Clinical cancer research (01.02.2021)
Published in Clinical cancer research (01.02.2021)
Get full text
Journal Article
Lung cancer stem cells: The root of resistance
MacDonagh, Lauren, Gray, Steven G, Breen, Eamon, Cuffe, Sinead, Finn, Stephen P, O'Byrne, Kenneth J, Barr, Martin P
Published in Cancer letters (28.03.2016)
Published in Cancer letters (28.03.2016)
Get full text
Journal Article
Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer
Pujol, Jean-Louis, Pirker, Robert, Lynch, Thomas J, Butts, Charles A, Rosell, Rafael, Shepherd, Frances A, Vansteenkiste, Johan, O’Byrne, Kenneth J, de Blas, Barbara, Heighway, Jim, von Heydebreck, Anja, Thatcher, Nick
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2014)
Get full text
Journal Article
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
Nowak, Anna K, Lesterhuis, W Joost, Kok, Peey-Sei, Brown, Chris, Hughes, Brett GM, Karikios, Deme J, John, Thomas, Kao, Steven C-H, Leslie, Connull, Cook, Alistair M, Pavlakis, Nick, Briscoe, Karen, O'Byrne, Kenneth J, Karapetis, Christos S, Lam, Wei-Sen, Langford, Ailsa, Yip, Sonia, Stockler, Martin R
Published in The lancet oncology (01.09.2020)
Published in The lancet oncology (01.09.2020)
Get full text
Journal Article
hSSB2 (NABP1) is required for the recruitment of RPA during the cellular response to DNA UV damage
Boucher, Didier, Kariawasam, Ruvini, Burgess, Joshua, Gimenez, Adrian, Ocampo, Tristan E., Ferguson, Blake, Naqi, Ali, Walker, Graeme J., Bolderson, Emma, Gamsjaeger, Roland, O’Byrne, Kenneth J., Cubeddu, Liza, Khanna, Kum Kum, Richard, Derek J.
Published in Scientific reports (12.10.2021)
Published in Scientific reports (12.10.2021)
Get full text
Journal Article
Human single-stranded DNA binding proteins are essential for maintaining genomic stability
Ashton, Nicholas W, Bolderson, Emma, Cubeddu, Liza, O'Byrne, Kenneth J, Richard, Derek J
Published in BMC molecular biology (01.04.2013)
Published in BMC molecular biology (01.04.2013)
Get full text
Journal Article